TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS Co-Infection
New findings in HIV/AIDS co-infection described from University of Bari
June 30th, 2009
According to a study from Bari, Italy, "To report the efficacy, tolerability, and pharmacokinetic effects of combined voriconazole and efavirenz treatment administered at therapeutic drug monitoring (TDM)-based adjusted doses to a patient with AIDS, cryptococcosis, and mild liver cirrhosis. SUMMARY: A 40-year-old man with AIDS (hemophiliac, antiretroviral-naive, plasma HIV-RNA = 290,000 copies/mL, CD4+ lymphocytes = 0), hepatitis C virus-related liver cirrhosis (Child-Pugh class A), and cryptococcal meningitis was failing standard antifungal therapies." "He received an antifungal-antiretroviral combination treatment based on the association of voriconazole plus...
Source: TB & Outbreaks Week (2009-06-30)
|
